Back to Global NewsPublished: 28 Feb 2026Download AppJoin TelegramWhy Aardvark's Trial Pause Could Reshape Rare‑Disease Investing#Aardvark Therapeutics#ARD-101#Prader-Willi Syndrome#Biotech#Phase 3 Trial#Investing#Rare DiseaseDownload AppJoin CommunityShare Article